Quoin Pharma reports positive clinical data for QRX003: skin healed, no adverse events in pediatric Netherton patient

Quoin Pharmaceuticals, Ltd.

After 6 weeks of daily whole-body QRX003, the pediatric Netherton patient's skin is almost completely healed.
Patient no longer requires antibiotics, antivirals, antihistamines, or glucocorticoids; pruritus eliminated.
Zero nightly sleep disturbances without sedating medication; first continuous uninterrupted sleep in patient's life.
No adverse events reported after 6 weeks of whole body treatment with QRX003.
Company expects to initiate whole body application on a second pediatric patient in a few weeks.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.